Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Liposome-based systems improve skin wound healing effectively.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

Targeting colon cancer stem cells might lead to better treatment results.

Microneedles improve drug delivery in various body parts, are safe and painless, and show promise in cosmetology, vaccination, insulin delivery, and other medical applications.

Older adults have a high rate of skin cancers like basal cell carcinoma and melanoma, mainly due to UV exposure and age.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Advanced human skin models improve drug development and could replace animal testing.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Small molecule drugs show promise for advancing regenerative medicine but still face development challenges.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

A blood pressure drug, diltiazem, may also help treat influenza.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

The document concludes that computational methods using networks and various data can improve the process of finding new uses for existing drugs.

A model called PM-DBiGRU was developed for analyzing sentiments in drug reviews, and it performed better than other models, but struggled with complex sentences and situations requiring background knowledge.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

The tattoo machine method safely delivers an average of 1,175 µg/cm² of medication into the skin.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

Certain microRNAs found in normal cells can effectively suppress various cancers.

Dermocosmetics help manage skin issues in cancer patients, improving outcomes and reducing treatment interruptions.

Tamoxifen caused hair loss in a 52-year-old woman.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Certain spices may help prevent and treat skin cancer, but more human trials are needed.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.